Trihexyphenidyl for acute life-threatening episodes due to a dystonic movement disorder in Rett syndrome

Movement Disorders

Volumn 25, Issue 3, 2010, Pages 385-389

  Gika, Artemis D ^a   Hughes, Elaine ^a   Goyal, Sushma ^a,b   Sparkes, Matthew ^b   Lin, Jean Pierre ^a  

^a EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^b KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acute life threatening episodes; Dystonia; Epilepsy; Rett syndrome; Trihexyphenidyl

Indexed keywords

ANTICONVULSIVE AGENT; BACLOFEN; BENZODIAZEPINE; GABAPENTIN; METHYL CPG BINDING PROTEIN 2; TIZANIDINE; TRIHEXYPHENIDYL;

ACUTE LIFE THREATENING EPISODE; ADOLESCENT; ADULT; ALERTNESS; APNEA; ARTICLE; BABINSKI REFLEX; CASE REPORT; CHILD; CYANOSIS; DEATH; DISEASE COURSE; DISEASE SEVERITY; DYSTONIA; DYSTONIC DISORDER; ELECTROENCEPHALOGRAPHY; EMERGENCY; EPILEPSY; EPILEPTIC DISCHARGE; FACE; FEMALE; GENE MUTATION; HEAD MOVEMENT; HEAD POSITION; HUMAN; HYPOXIA; JAW; LIMB MOVEMENT; MUSCLE STIFFNESS; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY TRACT DISEASE; RETT SYNDROME; SCHOOL CHILD; SCOLIOSIS; SEIZURE; SPIKE; TONIC SEIZURE; TREATMENT RESPONSE; VIDEORECORDING;

ADOLESCENT; ANTIPARKINSON AGENTS; CHILD; DYSTONIC DISORDERS; ELECTROCARDIOGRAPHY; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; FEMALE; HUMANS; RETT SYNDROME; TRIHEXYPHENIDYL; VIDEO RECORDING; YOUNG ADULT;

EID: 77649161725     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22926     Document Type: Article

References (16)

1. Hagberg B, Hanefeld F, Percy A, Skjeldal O. An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting Baden Baden, Germany, 11 September 2001. Eur J Paediatr Neurol 2002;6:293-297.
2. Temudo T, Maciel P, Sequeiros J. Abnormal movements in Rett syndrome are present before the regression period: a case study. Mov Dis 2007;22:2285-2287.
3. FitzGerald PM, Jankovic J, Percy AK. Rett syndrome and associated movement disorders. Mov Dis 1990;5:195-202.
4. Glaze DG. Neurophysiology of Rett syndrome. J Child Neurol 2005;20: 740-746.
5. Temudo T, Ramos E, Dias K, et al. Movement disorders in Rett syndrome: an analysis of 60 patients with detected MECP2 mutation and correlation with mutation type. Mov Dis 2008;23: 1384-1390.
6. Roze E, Cochen V, Sangla S, et al. Rett syndrome: an over-looked diagnosis in women with stereotypic hand movements, psychomotor retardation, parkinsonism and dystonia? Mov Dis 2007;22:387-433.
7. Temudo T, Rios M, Prior C, et al. Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment. Brain Dev 2009;31:46-51.
8. Wenk GL, Naidu S, Moser H. Altered neurochemical markers in Rett syndrome. Ann Neurol 1989;26:467.
9. Julu POO, Witt-Engerström I. Assessment of the maturity-related brainstem functions reveals the heterogeneous phenotypes and facilitates clinical management of Rett syndrome. Brain Dev 2005;27:S43-S53.
10. Julu POO, Kerr AM, Apartopoulos F, et al. Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder. Arch Dis Child 2001;85:29-37.
11. Fish DR, Sawyers D, Allen PJ, Blackkie JD, Lees AJ, Marsden CD. The effect of sleep on the dyskinetic movements of Parkinson'e disease, Gilles de la Tourettes syndrome, Huntington's disease and torsion dystonia. Arch Neurol 1991;48:210-214.
12. Moser SJ, Weber P, Lütschg J. Rett syndrome: clinical and electrophysiological aspects. Pediatr Neurol 2007;36:95-100.
13. Huppke P, Köhler K, Brockmann K, Stettner GM, Gärtner J. Treatment of epilepsy in Rett syndrome. Eur J Paediatr Neurol 2007;11;10-16.
14. Balash Y, Giladi N. Efficacy of pharmacological treatment of dystonia: evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options. Eur J Neurol 2004;11:361-370.
15. Fahn S. High dosage anticholinergic therapy in dystonia. Neurology 1983;33:1255-1261.
16. Julu POO, Witt-Engerström I, Hansen S, et al. Cardiorespiratory challenges in Rett's syndrome. Lancet 2008;371;1-2.